TNF and TNF receptor 1-associated periodic fever syndrome: While IL-1 inhibitors remain first-line treatment, TNF inhibition appears to be a valid and effective second-line therapeutic alternative in TRAPS, especially when IL-1 blockade is not tolerated or available.